Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2023 - 01 - 09 source : Www.sutrobio.com save search
Update on STRO-002 Program and Plans for Registrational Trial in Advanced Ovarian Cancer – Presentation
Published: 2023-01-09 (Crawled : 23:00) - sutrobio.com
STRO | $3.73 -1.06% -1.07% 720K
|
Health Technology
|
| O: 1.93%
H: 0.89%
C: -14.08%
stro-002 program trial presentation update cancer ovarian cancer
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer
Published: 2023-01-09 (Crawled : 22:00) - sutrobio.com
PCVX | $60.89 -1.15% -1.17% 670K
|
Health Technology
|
| O: -0.3%
H: 1.79%
C: 0.35%
STRO | $3.73 -1.06% -1.07% 720K
|
Health Technology
|
| O: 1.93%
H: 0.89%
C: -14.08%
stro-002 biopharma update cancer study ovarian cancer phase 1
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.